-
Sartorius and TheWell Bioscience Partner to Enable More Accurate Predictions in Drug Discovery
Biotech Newswire
April 10, 2024
TheWell Bioscience is a pioneer in the field of animal-free hydrogels and bioinks, critical components for the creation of 3D biomimicking platforms.
-
Research progress of dual-target CAR-T in China from the perspective of the ASCO 2023
Xiaobin/PharmaSources
June 27, 2023
At the ASCO this year, Gracell Bio announced the long-term follow-up data of its multi-center clinical study of CAR-T therapy with GC012F for recurrent/refractory multiple myeloma (R/R MM) in the form of oral report at the annual meeting.
-
NASDAQ Biopharma IPOs in the First Half of Q1 2022
David Orchard-Webb
March 01, 2022
So far in the first half of Q1 2022 seven biopharma companies have IPO’d on the NASDAQ.
-
Cell Therapy Expected to Treat Solid Tumors in the Future as a CAR-T cell Therapy Clinical Trial for Treating Gastric and Pancreatic Cancers was Accepted
PharmaSources/Xiaobin
June 17, 2020
CAR-T cells can be easily led to cancer cells by relying on this target, to wipe out cancer. However, there is no such apparent target that only exists in tumor cells instead of normal cells in solid tumors.
-
T-CURX GmbH Announces Senior Leadership Appointments to Significantly Bolster Clinical Team
PharmaSources
June 07, 2023
Appointments of co-founder Professor Michael Hudecek as Chief Medical Officer and Dr. Karl Schumacher as Chief Clinical Officer.
-
LIfT BioSciences and Minaris Regenerative Medicine Enter into a Development and Manufacturing Partnership for N-LIfT Allogeneic Neutrophil Based Cell Therapy
PharmaSources
February 16, 2023
LIfT BioSciences and Minaris Regenerative Medicine GmbH have entered into a development and manufacturing partnership for N-LIfT, LIfT’s first-in-class neutrophil progenitor based Leukocyte Infusion Therapy.
-
Cryoport Partners with Cell Matters to Deliver Cryopreservation Services
contractpharma
January 27, 2022
Further strengthens Cryport’s capabilities in the EMEA region.
-
Fujifilm Acquires Cell Therapy Mfg. Facility from Atara Biotherapeutics
contractpharma
January 27, 2022
Expands its advanced therapies CDMO business .
-
Leaps by Bayer leads $80M Series A financing for Cellino Biotech to autonomize stem cell therapy manufacturing
WorldPharmaNews
January 26, 2022
Cellino Biotech, Inc., an autonomous cell therapy manufacturing company, today announced the completion of a Series A financing of $80 million, led by the impact investment arm of Bayer AG - Leaps by Bayer - 8VC, and Humboldt Fund.
-
Lion TCR Receives FDA Fast Track Designation for its HBV-specific TCR T Cell Therapy for Hepatocellular Carcinoma
prnasia
December 23, 2021
Lion TCR Pte Ltd today announced that it has received Fast Track Designation from United States Food and Drug Administration (U.S. FDA) for LioCyx-M004, autologous T-cells transfected with mRNA encoding Hepatitis B surface antigen...